RESEARCH STARTER
Montreal Cognitive Assessment (MoCA)
The Montreal Cognitive Assessment (MoCA) is a widely recognized screening tool designed to identify cognitive impairment in individuals. Developed in Canada in 1996, MoCA has gained international use and is available in over forty languages, making it accessible in numerous clinical settings across nearly two hundred countries. The assessment consists of thirty questions divided into eleven sections, focusing on various cognitive abilities, including memory, attention, language, and executive function. A typical MoCA evaluation takes around ten to twelve minutes to complete, with scores ranging from 0 to 30; a score above 25 is generally regarded as normal, while scores below this indicate some degree of cognitive impairment.
Research indicates that MoCA may be more effective than the Mini-Mental State Examination (MMSE) in detecting subtle cognitive changes, particularly in populations at risk for neurological diseases such as Alzheimer’s. The test includes tasks such as drawing a clock and naming animals, which help to gauge a person's cognitive function in a practical manner. Overall, the MoCA serves as a valuable resource for clinicians to assess cognitive health and is instrumental in the early detection of dementia-related conditions.
Authored By: Caffrey, Cait 1 of 4
Published In: 2024 2 of 4
- Related Topics:
3 of 4
- Related Articles:A - 87 Exploring the Utility of the Montreal Cognitive Assessment to Identify Neurocognitive Deficits among Adult Patients with Sickle Cell Disease.;B - 114 Evaluation of the Montreal Cognitive Assessment Memory Index Score for Predicting Amnestic Mild Cognitive Impairment to Alzheimer's Clinical Syndrome Progression.;Evaluation of Cognition in Mild Cognitive Impairment and Cognitively Intact Group: A Follow Up Study.;Longitudinal Feasibility of the Montreal Cognitive Assessment (MoCA) in Non-Demented ALS Patients.;Montreal Cognitive Assessment Scores Do Not Associate With Communication Challenges Reported by Adults With Alzheimer's Disease or Parkinson's Disease.
4 of 4
Full Article
Montreal Cognitive Assessment (MoCA) is a screening tool used to determine the presence of cognitive impairment in an individual. First introduced in 1996 in Canada, the assessment has since been adopted by other countries and is utilized in a variety of clinical settings. MoCA is a thirty-point test that takes approximately ten minutes to complete and is available in more than forty languages. Any score above 26 is considered normal, and any score less than 26 suggests some level of cognitive impairment. MoCA assesses multiple cognitive areas such as short-term memory, visuospatial reasoning, executive function, concentration and attention, language processing and fluency, abstract reasoning, and mental orientation. Research has shown that the MoCA is effective in detecting cognitive impairment and may be useful in determining the presence of neurological disease involving dementia, such as Alzheimer's disease. Studies have also suggested the MoCA may be better at detecting cognitive impairment than the commonly used Mini-Mental State Examination (MMSE). Researchers indicate that MoCA is also used in conditions such as Parkinson’s disease, stroke recovery, and pre-surgical cognitive assessment, extending its use beyond dementia screening. Research also suggests that while MoCA assesses multiple domains, it may primarily reflect overall cognitive ability rather than fully distinct cognitive functions.
Overview
The MoCA was developed to assess levels of cognitive impairment in patients. The test comprises thirty questions that take between ten and twelve minutes to complete. The questions gauge a number of cognitive abilities from memory to language to abstract thought. The MoCA is free to any clinician (with required certification for official use), and it is available in about two hundred countries in over one hundred languages.
The test is presented in eleven sections with a maximum score of thirty points. Each section counts for a different number of points. The first section, "Alternating Trail Making," is worth one point and asks patients to draw a line between corresponding letters and numbers in ascending order without crossing lines. The second and third sections test a subject's "Visuoconstructional Skills." The second section, worth one point, instructs subjects to copy a drawing of a cube. The point is awarded if the drawing is relatively accurate. The third section, worth three points, asks the subject to draw a clock, with one point awarded for the drawing having a contour, numbers, and hands. The next section is called "Naming" and asks the test taker to name three common animals shown on the page, awarding one point for each correct answer.
The next section titled "Memory" awards no points and simply asks the subject to read five words they will be asked to recall later in the test. The test then moves on to section six, "Attention," which requires the patient to pay attention to verbal commands such as repeating digits, acknowledging spoken letters, and counting backward from one hundred by sevens. This section is worth six points. The test then moves on to "Sentence Repetition," asking the subject to repeat two spoken sentences for a total of two points per correct response. This is followed by "Verbal Fluency," with one point being awarded if the patient generates a sufficient number of words beginning with a specified letter. The ninth section, "Abstraction," is worth two points and gauges a patient's abstract thought by presenting pairs of words and seeing what commonalities the patient can identify among the pairs. The final two sections, "Delayed Recall" and "Orientation" are worth five points each. "Delayed Recall" asks the subject to recall the words read in "Memory." "Orientation" tests the patient's ability to determine the current time and place.
In 2024, the test became more accessible with the MoCA XpressO mobile application. The company designed the user-friendly application as a self-assessment of cognitive function through logical puzzles, memorization tasks, and grid-based activities. While it is not a diagnostic tool, it provides a score that corresponds to the MoCA test and prompts users to make an appointment with a medical professional if needed. Versions of MoCA include alternate forms, the Memory Index Score (MIS), and shorter adaptations such as MoCA-Basic and MoCA-Blind, reflecting increased flexibility in clinical use.
Bibliography
"About Us." Montreal Cognitive Assessment, mocacognition.com/about. Accessed 26 Mar. 2026.
Christensen, Jen. "This Is the Cognitive Test the President Passed." CNN, 25 Jan. 2018, www.cnn.com/2018/01/16/health/montreal-cognitive-assessment-mental-health-trump/index.html. Accessed 26 Mar. 2026.
Dong, YanHong, et al. "The Montreal Cognitive Assessment (MoCA) Is Superior to the Mini-Mental State Examination (MMSE) for the Detection of Vascular Cognitive Impairment after Acute Stroke." Journal of the Neurological Sciences, vol. 299, no. 1-2, 15 Dec. 2010, pp. 15-18, www.jns-journal.com/article/S0022-510X(10)00418-1/fulltext. Accessed 26 Mar. 2026.
Kang, Jae Myeong, et al. "Montreal Cognitive Assessment Reflects Cognitive Reserve." BMC Geriatrics, vol. 18, no. 261, 2018, www.ncbi.nlm.nih.gov/pmc/articles/PMC6208087. Accessed 26 Mar. 2026.
Klil-Drori, Sivan, et al. “Montreal Cognitive Assessment (MoCA) XpressO: Validation of a Digital Self-Administered Cognitive Prescreening Tool.” Journal of the American Geriatrics Society, vol. 72, no. 8, 2024, pp. 2516–22, doi:10.1111/jgs.18902. Accessed 26 Mar. 2026.
Medical News Today. "What is the MoCA test for dementia?" Medical News Today, 12 Sept. 2022, www.medicalnewstoday.com/articles/moca-test-for-dementia#uses. Accessed 26 Mar. 2026.
"MoCA Test." Montreal Cognitive Assessment, mocacognition.com/the-moca-test. Accessed 26 Mar. 2026.
Nasreddine, Ziad S. "Montreal Cognitive Assessment (MoCA)." ePROVIDE, Mapi Trust, eprovide.mapi-trust.org/instruments/montreal-cognitive-assessment. Accessed 26 Mar. 2026.
Rosenzweig, Andrew. "Montreal Cognitive Assessment (MoCA) Test for Dementia." Very Well Health, 21 Dec. 2025, www.verywellhealth.com/alzheimers-and-montreal-cognitive-assessment-moca-98617. Accessed 26 Mar. 2026.
Sergi, Maria Rita, et al. "Investigating the Factor Structure of the Montreal Cognitive Assessment: A Qualitative Review." Frontiers in Psychology, vol. 16, 17 Dec. 2025, doi:10.3389/fpsyg.2025.1727202. Accessed 26 Mar. 2026.
Zerenner, Tanja, et al. "Predicting Neuropsychological Testing Outcomes and Research Clinic Diagnosis of MCI and Dementia in Parkinson’s Disease Using the MoCA." medRxiv, 10 Aug. 2025, doi:10.1101/2025.06.30.25330565. Accessed 26 Mar. 2026.
Full Article
Montreal Cognitive Assessment (MoCA) is a screening tool used to determine the presence of cognitive impairment in an individual. First introduced in 1996 in Canada, the assessment has since been adopted by other countries and is utilized in a variety of clinical settings. MoCA is a thirty-point test that takes approximately ten minutes to complete and is available in more than forty languages. Any score above 26 is considered normal, and any score less than 26 suggests some level of cognitive impairment. MoCA assesses multiple cognitive areas such as short-term memory, visuospatial reasoning, executive function, concentration and attention, language processing and fluency, abstract reasoning, and mental orientation. Research has shown that the MoCA is effective in detecting cognitive impairment and may be useful in determining the presence of neurological disease involving dementia, such as Alzheimer's disease. Studies have also suggested the MoCA may be better at detecting cognitive impairment than the commonly used Mini-Mental State Examination (MMSE). Researchers indicate that MoCA is also used in conditions such as Parkinson’s disease, stroke recovery, and pre-surgical cognitive assessment, extending its use beyond dementia screening. Research also suggests that while MoCA assesses multiple domains, it may primarily reflect overall cognitive ability rather than fully distinct cognitive functions.
Overview
The MoCA was developed to assess levels of cognitive impairment in patients. The test comprises thirty questions that take between ten and twelve minutes to complete. The questions gauge a number of cognitive abilities from memory to language to abstract thought. The MoCA is free to any clinician (with required certification for official use), and it is available in about two hundred countries in over one hundred languages.
The test is presented in eleven sections with a maximum score of thirty points. Each section counts for a different number of points. The first section, "Alternating Trail Making," is worth one point and asks patients to draw a line between corresponding letters and numbers in ascending order without crossing lines. The second and third sections test a subject's "Visuoconstructional Skills." The second section, worth one point, instructs subjects to copy a drawing of a cube. The point is awarded if the drawing is relatively accurate. The third section, worth three points, asks the subject to draw a clock, with one point awarded for the drawing having a contour, numbers, and hands. The next section is called "Naming" and asks the test taker to name three common animals shown on the page, awarding one point for each correct answer.
The next section titled "Memory" awards no points and simply asks the subject to read five words they will be asked to recall later in the test. The test then moves on to section six, "Attention," which requires the patient to pay attention to verbal commands such as repeating digits, acknowledging spoken letters, and counting backward from one hundred by sevens. This section is worth six points. The test then moves on to "Sentence Repetition," asking the subject to repeat two spoken sentences for a total of two points per correct response. This is followed by "Verbal Fluency," with one point being awarded if the patient generates a sufficient number of words beginning with a specified letter. The ninth section, "Abstraction," is worth two points and gauges a patient's abstract thought by presenting pairs of words and seeing what commonalities the patient can identify among the pairs. The final two sections, "Delayed Recall" and "Orientation" are worth five points each. "Delayed Recall" asks the subject to recall the words read in "Memory." "Orientation" tests the patient's ability to determine the current time and place.
In 2024, the test became more accessible with the MoCA XpressO mobile application. The company designed the user-friendly application as a self-assessment of cognitive function through logical puzzles, memorization tasks, and grid-based activities. While it is not a diagnostic tool, it provides a score that corresponds to the MoCA test and prompts users to make an appointment with a medical professional if needed. Versions of MoCA include alternate forms, the Memory Index Score (MIS), and shorter adaptations such as MoCA-Basic and MoCA-Blind, reflecting increased flexibility in clinical use.
Bibliography
"About Us." Montreal Cognitive Assessment, mocacognition.com/about. Accessed 26 Mar. 2026.
Christensen, Jen. "This Is the Cognitive Test the President Passed." CNN, 25 Jan. 2018, www.cnn.com/2018/01/16/health/montreal-cognitive-assessment-mental-health-trump/index.html. Accessed 26 Mar. 2026.
Dong, YanHong, et al. "The Montreal Cognitive Assessment (MoCA) Is Superior to the Mini-Mental State Examination (MMSE) for the Detection of Vascular Cognitive Impairment after Acute Stroke." Journal of the Neurological Sciences, vol. 299, no. 1-2, 15 Dec. 2010, pp. 15-18, www.jns-journal.com/article/S0022-510X(10)00418-1/fulltext. Accessed 26 Mar. 2026.
Kang, Jae Myeong, et al. "Montreal Cognitive Assessment Reflects Cognitive Reserve." BMC Geriatrics, vol. 18, no. 261, 2018, www.ncbi.nlm.nih.gov/pmc/articles/PMC6208087. Accessed 26 Mar. 2026.
Klil-Drori, Sivan, et al. “Montreal Cognitive Assessment (MoCA) XpressO: Validation of a Digital Self-Administered Cognitive Prescreening Tool.” Journal of the American Geriatrics Society, vol. 72, no. 8, 2024, pp. 2516–22, doi:10.1111/jgs.18902. Accessed 26 Mar. 2026.
Medical News Today. "What is the MoCA test for dementia?" Medical News Today, 12 Sept. 2022, www.medicalnewstoday.com/articles/moca-test-for-dementia#uses. Accessed 26 Mar. 2026.
"MoCA Test." Montreal Cognitive Assessment, mocacognition.com/the-moca-test. Accessed 26 Mar. 2026.
Nasreddine, Ziad S. "Montreal Cognitive Assessment (MoCA)." ePROVIDE, Mapi Trust, eprovide.mapi-trust.org/instruments/montreal-cognitive-assessment. Accessed 26 Mar. 2026.
Rosenzweig, Andrew. "Montreal Cognitive Assessment (MoCA) Test for Dementia." Very Well Health, 21 Dec. 2025, www.verywellhealth.com/alzheimers-and-montreal-cognitive-assessment-moca-98617. Accessed 26 Mar. 2026.
Sergi, Maria Rita, et al. "Investigating the Factor Structure of the Montreal Cognitive Assessment: A Qualitative Review." Frontiers in Psychology, vol. 16, 17 Dec. 2025, doi:10.3389/fpsyg.2025.1727202. Accessed 26 Mar. 2026.
Zerenner, Tanja, et al. "Predicting Neuropsychological Testing Outcomes and Research Clinic Diagnosis of MCI and Dementia in Parkinson’s Disease Using the MoCA." medRxiv, 10 Aug. 2025, doi:10.1101/2025.06.30.25330565. Accessed 26 Mar. 2026.
More Like ThisRelated Articles
Related Articles (5)
Related Articles (5)
- A - 87 Exploring the Utility of the Montreal Cognitive Assessment to Identify Neurocognitive Deficits among Adult Patients with Sickle Cell Disease.Published In: Archives of Clinical Neuropsychology, 2024, v. 39, n. 7. P. 1025Authored By: Ulloa, Sara; Wong, Tiffany; Luo, Hua; Bao, Sile; Cavazos, Judith; Santos-Modesitt, Wendy; Treadwell, Marsha; Hagar, Ward; Hoehner, ChristinePublication Type: Academic Journal
- B - 114 Evaluation of the Montreal Cognitive Assessment Memory Index Score for Predicting Amnestic Mild Cognitive Impairment to Alzheimer's Clinical Syndrome Progression.Published In: Archives of Clinical Neuropsychology, 2024, v. 39, n. 7. P. 1216Authored By: Kronenberger, Oscar; Lacritz, Laura H; Nguyen, Trung P; Kaser, Alyssa; Longoria, Anthony; Lee, Diamond; Schaffert, JeffreyPublication Type: Academic Journal
- Evaluation of Cognition in Mild Cognitive Impairment and Cognitively Intact Group: A Follow Up Study.Published In: QJM: An International Journal of Medicine, 2024, v. 117. P. ii138Authored By: Sweed, Hala Samir; Yousif Kamal, Heba Yousif; Helmy El Malah, Dina Mostafa; Abbas Hassan, Marwa ElsayedPublication Type: Academic Journal
- Longitudinal Feasibility of the Montreal Cognitive Assessment (MoCA) in Non-Demented ALS Patients.Published In: European Neurology, 2024, v. 87, n. 2. P. 79Authored By: Aiello, Edoardo Nicolò; Solca, Federica; Torre, Silvia; Colombo, Eleonora; Maranzano, Alessio; De Lorenzo, Alberto; Patisso, Valerio; Treddenti, Mauro; Curti, Beatrice; Morelli, Claudia; Doretti, Alberto; Verde, Federico; Ferrucci, Roberta; Barbieri, Sergio; Ruggiero, Fabiana; Priori, Alberto; Silani, Vincenzo; Ticozzi, Nicola; Poletti, BarbaraPublication Type: Academic Journal
- Montreal Cognitive Assessment Scores Do Not Associate With Communication Challenges Reported by Adults With Alzheimer's Disease or Parkinson's Disease.Published In: American Journal of Speech-Language Pathology, 2024, v. 33, n. 4. P. 1902Authored By: Stagge, Faith; Lanzi, Alyssa M.; Saylor, Anna K.; Cohen, Matthew L.Publication Type: Academic Journal